-
Mashup Score: 2Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study - Beyond the Abstract - 7 month(s) ago
prostate cancer, Salvage Stereotactic Reirradiation, Prostatectomy, Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy, Local Recurrence in the Prostatic Bed, PSMA PET-CT, urethro-vesical anastomosis, stereotactic body radiotherapy (SBRT), prostate cancer survival, REPAIR GETUG P16 study, NCT04536805 study.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Incontinence Costs European Society over 40 Billion Euros per Year - 7 month(s) ago
economic burden of urinary incontinence, cost of continence care, 55-60 million Europeans suffer from continence health problems, European Association of Urology, EU Continence Health Summit.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The economic burden of urinary #incontinence in #Europe is staggering, costing over 40 billion Euros in 2023. Action is needed to address this growing health issue and its significant impact #HealthcareCosts. #ReadNow for details > https://t.co/RmReIYp4Qo @Uroweb https://t.co/krl84GSG9k
-
-
Mashup Score: 0BOP Preliminary Trial Results Presented at EANM 2023 Conference - 8 month(s) ago
Phase II diagnostic investigator-initiated trial (IIT) of 64Cu SAR-Bombesin in prostate cancer, BOP (NCT05613842), 64Cu SAR-Bombesin, prostate cancer, PSMA positron emission tomography (PET) imaging, metastatic castrate resistant prostate cancer (mCRPC).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Promising BOP preliminary trial results presented at #EANM23 conference. Congratulations to everyone involved! #ReadNow details on UroToday > https://t.co/zw1VqWbpsp @Clarity_Pharma @drlouiseemmett @EANM_NucMed https://t.co/6JB2vr1jeF
-
-
Mashup Score: 0Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study - Beyond the Abstract - 8 month(s) ago
prostate cancer, Salvage Stereotactic Reirradiation, Prostatectomy, Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy, Local Recurrence in the Prostatic Bed, PSMA PET-CT, urethro-vesical anastomosis, stereotactic body radiotherapy (SBRT), prostate cancer survival, REPAIR GETUG P16 study, NCT04536805 study.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Salvage stereotactic reirradiation for local recurrence in the prostatic bed after prostatectomy: a retrospective multicenter study. #BeyondTheAbstract with @ArcherPaul_ and @David__Pasquier. #ReadNow on UroToday > https://t.co/2KUf6veaf8 @EurUrolOncol https://t.co/wgQurWi4Fn
-
-
Mashup Score: 0Gene Regulatory Networks Underlying Cell Identity in Bladder Cancer - Expert Commentary - 8 month(s) ago
Muscle-invasive bladder cancer (MIBC), bladder cancer, luminal subtypes, Gene set enrichment analysis (GSEA), chromatin immunoprecipitation sequencing (ChIP-seq), immune checkpoint inhibitor therapy, genomic sequencing for bladder cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ReadNow Gene regulatory networks underlying cell identity in #BladderCancer. 🧬💥 Don't miss this #ExpertCommentary from @FaltasLab, unraveling the intricate mechanisms behind cell identity and its implications for diagnosis and treatment > https://t.co/spo7biogTT @NeyretHelene https://t.co/ybwnI4WbrF
-
-
Mashup Score: 1Effect of Genomic Subtypes of Urothelial Carcinoma on Response to Immune Checkpoint Inhibitors - Expert Commentary - 8 month(s) ago
immune checkpoint inhibitors (ICI), Urothelial Carcinoma, Genomic Subtypes of Urothelial Carcinoma, bladder cancer, Cancer Genome Atlas (TCGA), ARID1A mutation, bladder cancer survival rates.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ReadNow A fascinating study on the effect of genomic subtypes of #UrothelialCarcinoma on response to immune checkpoint inhibitors. 🧬💉 Check out this expert commentary from @FaltasLab @WCMEnglanderIPM for all the insights! 📚 @JCO_ASCO @MichalSarfaty > https://t.co/D73U4u6i28 https://t.co/t64Ldwnlpf
-
-
Mashup Score: 0Treatment of Localized Prostate Cancer in Elderly Patients: the Role of Partial Cryoablation - Beyond the Abstract - 8 month(s) ago
treatment of prostate cancer, Partial gland cryoablation, treating elderly patients with prostate cancer, focal treatment, Localized Prostate Cancer, older patients with advanced prostate cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ReadNow This intriguing article on the role of partial #cryoablation in the treatment of localized #ProstateCancer in elderly patients. ❄️🩺 #BeyondTheAbstract on UroToday > https://t.co/PiGaBWW1X4 @FinatiMarco #ElderlyCare @urologynephrol1 https://t.co/DQ4rQ1FfUo
-
-
Mashup Score: 1The Efficacy of First-Line Carboplatin in Metastatic Urothelial Carcinoma - Expert Commentary - 8 month(s) ago
KEYNOTE-361 study, advanced or metastatic urothelial carcinoma (AMUC), DANUBE study, carboplatin-based chemotherapy versus ICI monotherapy, Metastatic Urothelial Carcinoma, IMvigor130 study.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ReadNow this insightful #ExpertCommentary on the efficacy of first-line carboplatin in metastatic #UrothelialCarcinoma! 🧪🔬 @FaltasLab discusses work by Mori et al. in @EurUrolFocus > https://t.co/xyzgssp1Md #BladderCancer #MedicalResearch https://t.co/XTz7F8OIGQ
-
-
Mashup Score: 0
male cancer-related deaths worldwide, prostate specific antigen (PSA), PSA screening, digital rectal examination, MRI imaging for prostate cancer, prostate cancer screening improvements, detecting prostate cancer at an early stage.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#ProstateCancer screening-stepping forward with #MRI. #BeyondTheAbstract with @ProfPadhani @ScannerCentre and @IvoSchootsNL @ErasmusMC discussing advancements in utilizing MRI for early detection and diagnosis of prostate cancer. #ReadNow on UroToday > https://t.co/BcJqyP0Qvy https://t.co/K20Ds4uf1j
-
-
Mashup Score: 3
prostate cancer, urothelial carcinoma, bladder cancer, Antibody drug conjugates (ADCs), Enfortumab vedotin, HER2, Sacituzumab govitecan, ARX517 trial, PET imaging, breast cancer, prostate specific membrane antigen (PSMA), trophoblast cell-surface antigen 2 (TROP2), androgen targeting therapies, ARC-6 trial, Datopotamab deruxtecan, PETRA trial, disitamab vedotin, next generation prostate cancer treatment, new prostate cancer trials, B7H3.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The next revelation in #ProstateCancer therapy? Antibody-drug conjugates. #COE #Blog Evan Yu, MD @fredhutch discusses promising research, paving the way for targeted therapies with enhanced efficacy and fewer side effects. #ReadNow details on UroToday > https://t.co/XegjExRsOq https://t.co/R1DcQ6GdvM
-
Salvage stereotactic reirradiation for local recurrence in the prostatic bed after prostatectomy: a retrospective multicenter study. #BeyondTheAbstract with @ArcherPaul_ and @David__Pasquier. #ReadNow on UroToday > https://t.co/2KUf6veaf8 @EurUrolOncol https://t.co/8GJfLR4Yn1